Company Short-Term Debt: uniqure.com (QURE)

uniQure Corp - graphic logo of issuer QURE

uniQure N.V. (QURE) bases its competitive advantage on exclusive gene delivery patents and the complexity of navigating regulatory approvals. Within the biotech ecosystem, uniQure N.V. (QURE) retains patients through the uniqueness of its hemophilia therapy, with the indicator standing at 0.05. This chart on the GURU.Markets platform visualizes the price action of the asset, whose strategy relies on ESG standards, bioethics in research, and the reduction of harmful emissions.

QURE (uniQure) Short-Term Debt Volume history from 07/04/2022 to 11/01/2026

Summary analytical data breakdowns for uniQure Pharma (QURE)

- share price and expert price forecast:
Stock Quotes uniQure|QURE - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value uniQure N.V.|QURE - Business Value
- shareholders' equity book value data:
Book Value per Share uniQure|QURE - Book Valuation of Business|Market Value to Book Value Ratio uniqure.com|QURE - Company Balance Sheet Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio uniQure N.V.|QURE - Long-Term Debt to Capital|Short-Term Debt to Equity uniQure N.V.|QURE - Aggregate Debt Obligations|Debts to Book Capitalization uniQure N.V.|QURE - Long-Term Debt|Company Current Liabilities uniQure|Quick Liquidity uniqure.com
- net income and valuation multiples indicators:
QURE - Company Profit
General company analysis:uniQure (QURE)
Flagship merchandise of uniQure N.V.

uniQure N.V. represents the gene therapy biotechnology sector with a high liquidity reserve. This indicator captures the aggregate of all credit obligations due for repayment within the coming year. It is critical for investors to weigh these amounts against royalties from Hemgenix and the clinical trial costs for AMT-130. Low reliance on borrowing confirms financial stability. By analyzing current borrowed funds, one can assess the effectiveness of management's capital allocation.

Main competitors

TEM: Company Current Liabilities|QGEN - Company Short-Term Debts|Ionis Pharma (IONS) - Company Short-Term Debt|Company Short-Term Indebtedness RGEN|RNA (Avidity Biosciences) - Company Short-Term Debts|crisprtx.com (CRSP) - Short-Term Debt Volume|Company Short-Term Debt GeneDx (WGS)|Ultragenyx Pharmaceutical Inc. (RARE) - Short-Term Indebtedness|Beam Therapeutics Corp - Company Current Liabilities|Company Short-Term Debts Sarepta Corp SRPT|TWST - Company Short-Term Debt|Company Short-Term Loans and Borrowings TXG (10xgenomics.com)|NTLA: Company Short-Term Debts|Short-Term Debt Stoke Therapeutics Inc (STOK)|Company Current Liabilities BLFS|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debt Maze Therapeutics Inc (MAZE)|sionnatx.com - Company Short-Term Indebtedness|Prime Medicine - Company Current Liabilities|Short-Term Debt Volume Taysha Gene Therapies Inc (TSHA)|MGTX: Company Current Liabilities|RGNX: Company Short-Term Debt|SLDB (Solid Biosciences Inc.) - Company Current Liabilities|OCGN - Short-Term Debt Volume|Company Short-Term Debt PacBio|BNTC - Short-Term Indebtedness|Company Current Liabilities DSGN (Design Pharma)|Company Short-Term Debts Rocket Corp (RCKT)|Company Short-Term Debt 4D Molecular Therapeutics FDMT|Company Short-Term Loans and Borrowings LXEO|Korro Bio, Inc - Company Short-Term Debts|Short-Term Debt Editas Medicine Inc|SLN: Company Short-Term Debts|Company Short-Term Indebtedness PRQR|Company Short-Term Debt Codexis Inc|Company Short-Term Indebtedness SGMO (sangamo.com)|Company Short-Term Debts NAUT|Company Short-Term Debts Metagenomi Inc. (MGX)|Precision BioSciences - Company Current Liabilities|Company Short-Term Debts Generation Bio Co GBIO|BOLD - Company Short-Term Debt|XCUR (Exicure, Inc.) - Company Short-Term Indebtedness|IMNN: Company Short-Term Debts|PHIO - Short-Term Debt Volume|Company Short-Term Debt Mustang Bio Inc|RNAZ - Short-Term Indebtedness|Company Current Liabilities BNGO (Bionano Genomics, Inc.)|Company Short-Term Debts adnas.com (APDN)|Company Short-Term Debt bluebird bio BLUE|Company Short-Term Loans and Borrowings IPA|Omega - Company Short-Term Debts|Short-Term Debt Singular Genomics Corp|RGLS (Regulus Therapeutics) - Company Current Liabilities|syros.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Telesis Bio|Company Short-Term Indebtedness TCON (TRACON Pharmaceuticals Inc.)|Company Current Liabilities UBX (Unity Bio)